Great insights from Kevin Lanzo (Lionheart Ventures) at last week’s Psychedelic Therapeutics & Drug Development Conference in New Orleans. We discuss key developments that emerged during the conference and what they could mean for the field. Conducted as part of Cascades Analytics’ conference coverage, in partnership with Arrowhead SciTech Conferences & Events.